StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.50−0.13 (-7.67%)

Close on Nov 13, 2026Market cap $34.11MP/E –Yield –

BioHarvest Sciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$3.95M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.95M–
FY2024Dec 31, 2024-$5.74M–
FY2023Dec 31, 2023-$9.13M–

More BioHarvest Sciences figures

See a number that looks wrong?